DA-5222-R1
Sponsors
Dong-A ST Co., Ltd.
Conditions
Healthy
Phase 1
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects
Not yet recruitingNCT06993181
Start: 2025-06-30End: 2025-07-31Target: 48Updated: 2025-06-06
Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State
CompletedNCT07046715
Start: 2025-07-07End: 2025-08-19Updated: 2025-11-17